Continuous SSRI Treatment Key to Relapse Prevention in BDD Continuous SSRI Treatment Key to Relapse Prevention in BDD
Patients with body dysmorphic disorder who respond well to initial treatment with an SSRI should continue pharmacotherapy indefinitely to prevent relapse.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news
More News: Body Dysmorphic Disorder (BDD) | Psychiatry